TCL Archive NCI Director Andrew von Eschenbach To Resign June 10, Remain As FDA Acting Commissioner. June 2, 2006
TCL Archive FDA Approves Gilotrif Tablets in NSCLC, Boehringer Ingelheim’s First Approved Cancer Drug July 26, 2013
TCL Archive In Brief: Peter Greenwald A Leading Candidate For One Of Three Top NCI Jobs Remaining To Be Filled August 7, 1981
